We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVR icon
3001
Invesco Mortgage Capital
IVR
$682M
$36.7K ﹤0.01%
4,642
+1,505
+48% +$12.1K
FSBW icon
3002
FS Bancorp
FSBW
$348M
$36.6K ﹤0.01%
844
-164
-16% -$6.72K
CBRL icon
3003
Cracker Barrel
CBRL
$1.2B
$36.6K ﹤0.01%
686
-2,146
-76% -$74.3K
HOV icon
3004
Hovnanian Enterprises
HOV
$685M
$36.5K ﹤0.01%
256
-230
-47% -$26.3K
CIA icon
3005
Citizens
CIA
$183M
$36.4K ﹤0.01%
6,344
-2,115
-25% -$11.5K
ADTN icon
3006
Adtran
ADTN
$554M
$36.4K ﹤0.01%
2,617
-5,475
-68% -$85.4K
DAO
3007
Youdao
DAO
$1.78B
$36.4K ﹤0.01%
2,957
+2,089
+241% +$23.5K
BRCC icon
3008
BRC Inc
BRCC
$131M
$36.4K ﹤0.01%
3,276
+1,745
+114% +$21.6K
LXFR icon
3009
Luxfer Holdings
LXFR
$467M
$36.4K ﹤0.01%
2,015
-3,763
-65% -$58.7K
TRS icon
3010
TriMas Corp
TRS
$1.4B
$36.3K ﹤0.01%
807
-2,275
-74% -$90.5K
STLN
3011
Starling Oncology
STLN
$686M
$36.3K ﹤0.01%
6,681
-633
-9% -$2.66K
MAX icon
3012
MediaAlpha
MAX
$493M
$36.3K ﹤0.01%
2,886
-201
-7% -$1.9K
SFST icon
3013
Southern First Bancshares
SFST
$572M
$36.2K ﹤0.01%
593
-581
-49% -$33.5K
XFOR icon
3014
X4 Pharmaceuticals
XFOR
$298M
$36.2K ﹤0.01%
7,745
+7,565
+4,203% +$31K
LOCO icon
3015
El Pollo Loco
LOCO
$427M
$36.1K ﹤0.01%
2,131
-381
-15% -$5.45K
ELE
3016
Elemental Royalty Corp
ELE
$1.52B
$36.1K ﹤0.01%
+2,070
New +$36.3K
FCCO icon
3017
First Community Corp
FCCO
$309M
$36K ﹤0.01%
1,101
+290
+36% +$8.89K
LEVI icon
3018
Levi Strauss
LEVI
$7.54B
$36K ﹤0.01%
1,448
+1,269
+709% +$28.6K
GSLC icon
3019
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.2B
$35.9K ﹤0.01%
253
-14,967
-98% -$2.07M
XNET
3020
Xunlei
XNET
$314M
$35.9K ﹤0.01%
6,415
+6,028
+1,558% +$34.8K
GSUS icon
3021
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.5B
$35.9K ﹤0.01%
348
-14,186
-98% -$1.42M
VTS icon
3022
Vitesse Energy
VTS
$708M
$35.9K ﹤0.01%
2,274
-2,806
-55% -$49.7K
EGHT icon
3023
8x8 Inc
EGHT
$329M
$35.8K ﹤0.01%
20,943
+11,319
+118% +$22.8K
IWX icon
3024
iShares Russell Top 200 Value ETF
IWX
$3.85B
$35.8K ﹤0.01%
340
-8,730
-96% -$884K
BNTC icon
3025
Benitec Biopharma
BNTC
$340M
$35.8K ﹤0.01%
2,672
-384
-13% -$4.55K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.